VANECK BIONIC ENGINEERING UCITS ETF - USD |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| - CHF | -.--% |
|
-.--% | -.--% |
Investment objective
VanEcks Bionic Engineering ETF tracks the performance of the portfolio of innovative companies delivering medical, dental or vision-related implants, bioprinting, prosthesis, or preservation of organs and tissue.
| Name |
Price
|
Change
|
5d. change
|
1st Jan change
|
Weight
| |
|---|---|---|---|---|---|---|
| 329.4 AUD | +0.45% | +2.97% | +10.29% | -.--% | ||
| 290.8 CHF | +0.64% | +2.00% | +6.05% | -.--% | ||
| 118 CHF | +1.83% | +0.21% | -13.02% | -.--% | ||
| 334.1 DKK | +2.48% | +2.52% | +12.91% | -.--% | ||
| 82.31 USD | -1.15% | +1.01% | -0.08% | -.--% | ||
| 33.97 EUR | -0.09% | +0.27% | +8.39% | -.--% | ||
| 110,200 KRW | -0.27% | -2.91% | -15.88% | -.--% | ||
| 1.62 HKD | 0.00% | -3.57% | -31.06% | -.--% | ||
| 6.24 HKD | -1.58% | +5.23% | -25.89% | -.--% | ||
| 9.94 USD | +4.74% | -2.83% | -34.22% | -.--% | ||
More news
In partnership with
Description
| IE0005TF96I9 | |
|---|---|
| Total Expense Ratio | 0.55% |
| Asset Class | |
| Sector | |
| Size | |
| Currency | |
| Provider | |
| Underlying | MVIS Global Bionic Healthcare ESG Index (NTR) - USD |
Features and characteristics
| Jurisdiction | |
| Replication Method | |
| Replication Model | |
| Date of creation |
2022-11-30
|
| Dividend Policy | |
| Geographical Focus |
AuM evolution ( 2024-04-29 )
| AuM (EUR) | 6 M€ |
|---|---|
| AuM 1M | 6 M€ |
| AuM 3 months | 6 M€ |
| AuM 6 months | 4 M€ |
| AuM 12 months | 5 M€ |
- Stock Market
- ETF
- CYBO ETF
